MAIA Biotechnology Inc. announced results showing a favorable interim survival benefit from its lead clinical candidate THIO, a telomere-targeting treatment for patients with advanced non-small cell lung cancer.
Matteo Paz, 18, of Pasadena, CA, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.’s longest-running and most distinguished science, technology, engineering, and math competition for high school seniors (The Cancer Letter, March 7, 2025).
